Systematic Review and Proportional Meta-Analysis of Endarterectomy and Endovascular Therapy with Routine or Selective Stenting for Common Femoral Artery Atherosclerotic Disease

Table 4

Clinical efficacy as demonstrated by pooled analysis of identified outcomes between the different treatment strategies.

Variable	EVT - Selective Stenting	EVT- Routine Stenting	CFE
Primary Patency at 1 yr [95% CI] [I^2, p]	78%  69-85  69.37%, p= 0.006	84%  75-92  75.52%, p=0.0004	93%  90-96  74.91%, p < 0.0001
Primary Assisted Patency at 1 yr [95% CI] [I^2, p]	86%  67-97  91.8%, p < 0.0001	94%  83-99  81.29%, p = 0.0011	97%  94-99  90.87%, p < 0.0001
Target Lesion revascularization at 1 yr [95% CI] [I^2, p]	19%  14-23  22.3%, p = 0.27	8%  4-13   38.76%, p = 0.1628	4.5%  1-9  85.07%, p < 0.0001
Amputations [95% CI] [I^2, p]	3%  1.3 to 5.3   14.5%, p=0.31	3%  1-6  0.36%, p=0.4	4.5 2.5- 6.8  75.32%, p< 0.0001
30 days mortality [95% CI] [I^2, p]	1%  0.4-2  0%, p=0.43	0.8%  0.1-2  0%, p=0.9	1.3%  0.6-2  0%, p=0.56
Local complications [95% CI] [I^2, p]	7%  3.3 to 11.8  77.08%, p=0.0001	5.2  1.8- 10.2  56.89%, p=0.04	22.3%  13.8-32  95.2%, p < 0.0001

An I² more than 50% and a p less than 0.05 showing heterogeneity. Yr: year and CI: confidence interval.